{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:42:00Z","timestamp":1791319320235,"version":"4.3.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jacc.2025.09.1595","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:57:53Z","timestamp":1760198273000},"page":"157-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia"],"prefix":"10.1016","volume":"87","author":[{"given":"Pablo B.","family":"Nery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.L.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratika","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff S.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne","family":"Gula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3303-1490","authenticated-orcid":false,"given":"Girish M.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidal","family":"Essebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc W.","family":"Deyell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Sarrazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Amit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"AbdelWahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9035-3341","authenticated-orcid":false,"given":"Navjot","family":"Sandila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9602-2751","authenticated-orcid":false,"given":"John L.","family":"Sapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.jacc.2025.09.1595_bib1","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.jacc.2025.09.1595_bib2","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacc.2025.09.1595_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.hrthm.2021.10.010","article-title":"Trends in implantable cardioverter-defibrillator programming practices and its impact on therapies: Insights from a North American Remote Monitoring Registry 2007-2018","volume":"19","author":"Bennett","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.09.1595_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ahj.2017.03.009","article-title":"Effects of implantable cardioverter\/defibrillator shock and antitachycardia pacing on anxiety and quality of life: a MADIT-RIT substudy","volume":"189","author":"Perini","year":"2017","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.jacc.2025.09.1595_bib5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.hrthm.2017.12.026","article-title":"Defibrillator shocks and their effect on objective and subjective patient outcomes: results of the PainFree SST clinical trial","volume":"15","author":"Sears","year":"2018","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.jacc.2025.09.1595_bib6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacep.2023.01.030","article-title":"Ventricular tachycardia and ICD therapy burden with catheter ablation versus escalated antiarrhythmic drug therapy","volume":"9","author":"Samuel","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.09.1595_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jacep.2019.11.012","article-title":"Mortality risk increases with clustered ventricular arrhythmias in patients with implantable cardioverter-defibrillators","volume":"6","author":"Elsokkari","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"40","key":"10.1016\/j.jacc.2025.09.1595_bib8","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.jacc.2025.09.1595_bib9","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jacc.2017.10.053","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jacc.2025.09.1595_bib10","first-page":"822","article-title":"2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society position statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease","volume":"36","author":"Deyell","year":"2020","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2025.09.1595_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.jacc.2025.09.1595_bib12","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199906173402402","article-title":"Prevention of implantable-defibrillator shocks by treatment with sotalol","volume":"340","author":"Pacifico","year":"1999","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jacc.2025.09.1595_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007600","article-title":"Antiarrhythmic drugs or catheter ablation in the management of ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Kheiri","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.jacc.2025.09.1595_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jacc.2025.09.1595_bib15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa2409501","article-title":"Catheter ablation or antiarrhythmic drugs for ventricular tachycardia","volume":"392","author":"Sapp","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.1595_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2024.04.009","article-title":"A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: the VANISH2 trial","volume":"274","author":"Sapp","year":"2024","journal-title":"Am Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2025.09.1595_bib17","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.hrthm.2015.11.018","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"13","author":"Wilkoff","year":"2016","journal-title":"Heart Rhythm"},{"issue":"9708","key":"10.1016\/j.jacc.2025.09.1595_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"issue":"26","key":"10.1016\/j.jacc.2025.09.1595_bib19","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy","volume":"357","author":"Reddy","year":"2007","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jacc.2025.09.1595_bib20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","article-title":"Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial","volume":"141","author":"Willems","year":"2020","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacc.2025.09.1595_bib21","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","article-title":"Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial","volume":"145","author":"Della Bella","year":"2022","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacc.2025.09.1595_bib22","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/CIRCULATIONAHA.122.060039","article-title":"First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial","volume":"145","author":"Tung","year":"2022","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.jacc.2025.09.1595_bib23","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2022.01.050","article-title":"Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia","volume":"79","author":"Arenal","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.09.1595_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.jacc.2025.09.1595_bib25","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jacc.2011.07.036","article-title":"Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses","volume":"58","author":"Saksena","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.jacc.2025.09.1595_bib26","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1161\/CIRCULATIONAHA.109.853689","article-title":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial","volume":"120","author":"Packer","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jacc.2025.09.1595_bib27","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.hrthm.2016.03.004","article-title":"Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Santangeli","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2025.09.1595_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.39489.687894.DE","article-title":"Slow ventricular tachycardia","volume":"337","author":"Leitz","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jacc.2025.09.1595_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/jce.12867","article-title":"Sudden cardiac death despite a functional cardioverter-defibrillator: the case for early and aggressive therapy for ventricular tachycardia in selected patients","volume":"27","author":"Montgomery","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2025.09.1595_bib30","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/j.jacep.2025.08.025","article-title":"Ventricular tachycardia cycle length and response to rhythm control therapy: insights from the VANISH trial","volume":"11","author":"Samuel","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.09.1595_bib31","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0735-1097(97)00220-9","article-title":"Adverse effects of low dose amiodarone: a meta-analysis","volume":"30","author":"Vorperian","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacc.2025.09.1595_bib32","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00392-010-0181-3","article-title":"Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?","volume":"99","author":"Schwaiblmair","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2025.09.1595_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12258","article-title":"Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy","volume":"35","author":"Rankin","year":"2017","journal-title":"Cardiovasc Ther"},{"issue":"12","key":"10.1016\/j.jacc.2025.09.1595_bib34","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.amjcard.2019.09.008","article-title":"Meta-analysis comparing the relative risk of adverse events for amiodarone versus placebo","volume":"124","author":"Ruzieh","year":"2019","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.jacc.2025.09.1595_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00756-2024","article-title":"Diffuse lung diseases ascribed to drugs: a nationwide observational study over 37 years using the French Pharmacovigilance Database","volume":"65","author":"Yavordios","year":"2025","journal-title":"Eur Respir J"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725095221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725095221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:30:30Z","timestamp":1768923030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725095221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0735109725095221"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.09.1595","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.09.1595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}